Skip to main content
Erschienen in: The Cerebellum 5/2014

01.10.2014 | Original Paper

Comprehensive Study of Early Features in Spinocerebellar Ataxia 2: Delineating the Prodromal Stage of the Disease

verfasst von: Luis Velázquez-Pérez, Roberto Rodríguez-Labrada, Edilia M. Cruz-Rivas, Juan Fernández-Ruiz, Israel Vaca-Palomares, Jandy Lilia-Campins, Bulmaro Cisneros, Arnoy Peña-Acosta, Yaimeé Vázquez-Mojena, Rosalinda Diaz, Jonathan J. Magaña-Aguirre, Tania Cruz-Mariño, Annelié Estupiñán-Rodríguez, José M. Laffita-Mesa, Rigoberto González-Piña, Nalia Canales-Ochoa, Yanetza González-Zaldivar

Erschienen in: The Cerebellum | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

The prodromal phase of spinocerebellar ataxias (SCAs) has not been systematically studied. Main findings come from a homogeneous SCA type 2 (SCA2) population living in Cuba. The aim of this study was to characterize extensively the prodromal phase of SCA2 by several approaches. Thirty-seven non-ataxic SCA2 mutation carriers and its age- and sex-matched controls underwent clinical assessments, including standardized neurological exam, structured interviews and clinical scales, and looking for somatic and autonomic features, as well as a neuropsychological battery, antisaccadic recordings, and MRI scans. Main clinical somatic features of non-ataxic mutation carriers were cramps, sensory symptoms, sleep disorders, and hyperreflexia, whereas predominating autonomic symptoms were pollakiuria/nocturia, constipation, and frequent throat clearing. Cognitive impairments included early deficits of executive functions and visual memory, suggesting the involvement of cerebro-cerebellar-cerebral loops and/or reduced cholinergic basal forebrain input to the cortex. Antisaccadic task revealed impaired oculomotor inhibitory control but preserved ability for error correction. Cognitive and antisaccadic deficits were higher as carriers were closer to the estimated onset of ataxia, whereas higher Scale for the Assessment and Rating of Ataxia (SARA) scores were associated most notably to vermis atrophy. The recognition of early features of SCA2 offers novel insights into the prodromal phase and physiopathological base of the disease, allowing the assessment of its progression and the efficacy of treatments, in particular at early phases when therapeutical options should be most effective.
Literatur
1.
Zurück zum Zitat Velázquez-Pérez L, Rodríguez-Labrada R, García-Rodríguez JC, Almaguer-Mederos LE, Cruz-Mariño T, Laffita-Mesa JM. A comprehensive review of spinocerebellar ataxia type 2 in cuba. Cerebellum. 2011;10:184–98.PubMedCrossRef Velázquez-Pérez L, Rodríguez-Labrada R, García-Rodríguez JC, Almaguer-Mederos LE, Cruz-Mariño T, Laffita-Mesa JM. A comprehensive review of spinocerebellar ataxia type 2 in cuba. Cerebellum. 2011;10:184–98.PubMedCrossRef
2.
Zurück zum Zitat Velazquez-Perez L, Cruz GS, Santos Falcon N, et al. Molecular epidemiology of spinocerebellar ataxias in Cuba: insights into SCA2 founder effect in Holguin. Neurosci Lett. 2009;454(2):157–60.PubMedCrossRef Velazquez-Perez L, Cruz GS, Santos Falcon N, et al. Molecular epidemiology of spinocerebellar ataxias in Cuba: insights into SCA2 founder effect in Holguin. Neurosci Lett. 2009;454(2):157–60.PubMedCrossRef
3.
Zurück zum Zitat Orozco-Diaz G, Nodarse-Fleites A, Cordoves-Sagaz R, Auburger G. Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguin, Cuba. Neurology. 1990;40:1369–75.PubMedCrossRef Orozco-Diaz G, Nodarse-Fleites A, Cordoves-Sagaz R, Auburger G. Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguin, Cuba. Neurology. 1990;40:1369–75.PubMedCrossRef
4.
Zurück zum Zitat Jacobi H, Bauer P, Giunti P, et al. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology. 2011;77:1035–41.PubMedCentralPubMedCrossRef Jacobi H, Bauer P, Giunti P, et al. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology. 2011;77:1035–41.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Schmitz-Hubsch T, Coudert M, Bauer P, et al. Spinocerebellar ataxia type 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008;71:982–9.PubMedCrossRef Schmitz-Hubsch T, Coudert M, Bauer P, et al. Spinocerebellar ataxia type 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008;71:982–9.PubMedCrossRef
6.
Zurück zum Zitat Cruz-Mariño T, Velázquez-Pérez L, Gonzalez-Zaldivar Y, et al. The Cuban program for predictive testing of SCA2: 11 years and 768 individuals to learn from. Clin Genet. 2013;83:518–24.PubMedCrossRef Cruz-Mariño T, Velázquez-Pérez L, Gonzalez-Zaldivar Y, et al. The Cuban program for predictive testing of SCA2: 11 years and 768 individuals to learn from. Clin Genet. 2013;83:518–24.PubMedCrossRef
7.
Zurück zum Zitat Velazquez Perez L, Sanchez Cruz G, Canales Ochoa N, et al. Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2. J Neurol Sci. 2007;263:158–64.PubMedCrossRef Velazquez Perez L, Sanchez Cruz G, Canales Ochoa N, et al. Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2. J Neurol Sci. 2007;263:158–64.PubMedCrossRef
8.
Zurück zum Zitat Velázquez-Pérez L, Díaz R, Pérez-González R, et al. Motor decline in presymptomatic spinocerebellar ataxia type 2 gene carriers. PLoS ONE. 2009;4(4):5398–402.CrossRef Velázquez-Pérez L, Díaz R, Pérez-González R, et al. Motor decline in presymptomatic spinocerebellar ataxia type 2 gene carriers. PLoS ONE. 2009;4(4):5398–402.CrossRef
9.
Zurück zum Zitat Velázquez-Perez L, Rodriguez-Labrada R, Canales-Ochoa N, et al. Progression markers of spinocerebellar ataxia 2. A twenty years neurophysiological follow up study. J Neurol Sci. 2010;290:22–6.PubMedCrossRef Velázquez-Perez L, Rodriguez-Labrada R, Canales-Ochoa N, et al. Progression markers of spinocerebellar ataxia 2. A twenty years neurophysiological follow up study. J Neurol Sci. 2010;290:22–6.PubMedCrossRef
10.
Zurück zum Zitat Rodriguez-Labrada R, Velazquez-Pérez L, Canales-Ochoa N, et al. Subtle rapid eye movement sleep abnormalities in presymptomatic spinocerebellar ataxia type 2 gene carriers. Mov Disord. 2011;26:347–50.PubMedCrossRef Rodriguez-Labrada R, Velazquez-Pérez L, Canales-Ochoa N, et al. Subtle rapid eye movement sleep abnormalities in presymptomatic spinocerebellar ataxia type 2 gene carriers. Mov Disord. 2011;26:347–50.PubMedCrossRef
11.
Zurück zum Zitat Velázquez-Pérez L, Seifried C, Abele M, et al. Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2. Clin Neurophysiol. 2009;120(3):632–5.PubMedCrossRef Velázquez-Pérez L, Seifried C, Abele M, et al. Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2. Clin Neurophysiol. 2009;120(3):632–5.PubMedCrossRef
12.
Zurück zum Zitat Velázquez-Pérez L, Rodríguez-Labrada R, Canales-Ochoa N, et al. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study. Lancet Neurol. 2014;13(5):482–9.PubMedCrossRef Velázquez-Pérez L, Rodríguez-Labrada R, Canales-Ochoa N, et al. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study. Lancet Neurol. 2014;13(5):482–9.PubMedCrossRef
13.
Zurück zum Zitat Globas C, du Montcel ST, Baliko L, et al. Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Mov Disord. 2008;23(15):2232–8.PubMedCrossRef Globas C, du Montcel ST, Baliko L, et al. Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Mov Disord. 2008;23(15):2232–8.PubMedCrossRef
14.
Zurück zum Zitat Jacobi H, Reetz K, Tezenas du Montcel S, et al. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Lancet Neurol. 2013;12(7):650–8.PubMedCrossRef Jacobi H, Reetz K, Tezenas du Montcel S, et al. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Lancet Neurol. 2013;12(7):650–8.PubMedCrossRef
15.
Zurück zum Zitat Almaguer-Mederos LE, Falcón NS, Almira YR, et al. Estimation of the age at onset in spinocerebellar ataxia type 2 Cuban patients by survival analysis. Clin Genet. 2010;78(2):169–74.PubMedCrossRef Almaguer-Mederos LE, Falcón NS, Almira YR, et al. Estimation of the age at onset in spinocerebellar ataxia type 2 Cuban patients by survival analysis. Clin Genet. 2010;78(2):169–74.PubMedCrossRef
16.
Zurück zum Zitat Denny-Brown D, Dawson DM, Tyler HR. Handbook of neurological examination and case recording. 3rd ed. Cambridge: Harvard University Press; 1982. Denny-Brown D, Dawson DM, Tyler HR. Handbook of neurological examination and case recording. 3rd ed. Cambridge: Harvard University Press; 1982.
17.
Zurück zum Zitat Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717–20.PubMedCrossRef Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717–20.PubMedCrossRef
18.
Zurück zum Zitat Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord. 2004;11(19):1306–12.CrossRef Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord. 2004;11(19):1306–12.CrossRef
19.
Zurück zum Zitat Torralva T, Roca M, Gleichegerrcht E, Lopez P, Manes F. INECO Frontal Screening (IFS): A brief, sensitive, and specific tool to assess executive functions in dementia. J Int Neuropsychol Soc. 2009;1–10. Torralva T, Roca M, Gleichegerrcht E, Lopez P, Manes F. INECO Frontal Screening (IFS): A brief, sensitive, and specific tool to assess executive functions in dementia. J Int Neuropsychol Soc. 2009;1–10.
20.
Zurück zum Zitat Spreen O, Strauss E. A compendium of neuropsychological tests: administration norms, and commentary. New York: Oxford University Press; 1991. Spreen O, Strauss E. A compendium of neuropsychological tests: administration norms, and commentary. New York: Oxford University Press; 1991.
21.
Zurück zum Zitat Spreen O, Benton AL. Neurosensory center comprehensive examination for aphasia (NCCA). Victoria: University of Victoria, Neuropsychology Laboratory; 1969. Spreen O, Benton AL. Neurosensory center comprehensive examination for aphasia (NCCA). Victoria: University of Victoria, Neuropsychology Laboratory; 1969.
22.
Zurück zum Zitat Channon S, Daum I, Polkey CE. The effect of categorization on verbal memory after temporal lobectomy. Neuropsychologia. 1989;27:777–85.PubMedCrossRef Channon S, Daum I, Polkey CE. The effect of categorization on verbal memory after temporal lobectomy. Neuropsychologia. 1989;27:777–85.PubMedCrossRef
23.
Zurück zum Zitat Robbins TW, James M, Owen AM, et al. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia. 1994;5(5):266–81.PubMed Robbins TW, James M, Owen AM, et al. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia. 1994;5(5):266–81.PubMed
24.
Zurück zum Zitat Egerhazi A, Berecz R, Bartok E, Degrell I. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer’s disease. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31:746–51.CrossRef Egerhazi A, Berecz R, Bartok E, Degrell I. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer’s disease. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31:746–51.CrossRef
25.
Zurück zum Zitat Evdokimidis I, Smyrnis N, Constantinidis TS, et al. The antisaccade task in a sample of 2006 young men. I. Normal population characteristics. Exp Brain Res. 2002;147(1):45–52.PubMedCrossRef Evdokimidis I, Smyrnis N, Constantinidis TS, et al. The antisaccade task in a sample of 2006 young men. I. Normal population characteristics. Exp Brain Res. 2002;147(1):45–52.PubMedCrossRef
26.
Zurück zum Zitat Schmahmann JD, Doyon J, Toga AW, Petrides M, Evans AC. MRI atlas of the human cerebellum. San Diego: Academic Press; 2000. Schmahmann JD, Doyon J, Toga AW, Petrides M, Evans AC. MRI atlas of the human cerebellum. San Diego: Academic Press; 2000.
27.
Zurück zum Zitat Kanai K, Kuwabara S. Motor nerve hyperexcitability and muscle cramps in machado-joseph disease. Arch Neurol. 2009;66(1):139.PubMedCrossRef Kanai K, Kuwabara S. Motor nerve hyperexcitability and muscle cramps in machado-joseph disease. Arch Neurol. 2009;66(1):139.PubMedCrossRef
28.
Zurück zum Zitat Estrada R, Galarraga J, Orozco G, et al. Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies characterize it as an olivo-ponto-cerebellar atrophy (OPCA) plus. Acta Neuropathol. 1999;97:306–10.PubMedCrossRef Estrada R, Galarraga J, Orozco G, et al. Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies characterize it as an olivo-ponto-cerebellar atrophy (OPCA) plus. Acta Neuropathol. 1999;97:306–10.PubMedCrossRef
29.
Zurück zum Zitat Purves D, Augustine GJ, Fitzpatrick D, et al. Upper motor neuron control of the brainstem and spinal cord. In: Purves D, Augustine GJ, Fitzpatrick D, et al., editors. Neuroscience. 2nd ed. Sunderland: Sinauer Associates; 2001. Purves D, Augustine GJ, Fitzpatrick D, et al. Upper motor neuron control of the brainstem and spinal cord. In: Purves D, Augustine GJ, Fitzpatrick D, et al., editors. Neuroscience. 2nd ed. Sunderland: Sinauer Associates; 2001.
30.
Zurück zum Zitat Hoche F, Balikó L, den Dunnen W, et al. Spinocerebellar ataxia type 2 (sca2): identification of early brain degeneration in one monozygous twin in the initial disease stage. Cerebellum. 2011;10(2):245–53.PubMedCrossRef Hoche F, Balikó L, den Dunnen W, et al. Spinocerebellar ataxia type 2 (sca2): identification of early brain degeneration in one monozygous twin in the initial disease stage. Cerebellum. 2011;10(2):245–53.PubMedCrossRef
31.
Zurück zum Zitat Inagaki A, Iida A, Matsubara M, Inagaki H. Positron emission tomography and magnetic resonance imaging in spinocerebellar ataxia type 2: a study of symptomatic and asymptomatic individuals. Eur J Neurol. 2005;12(9):725–8.PubMedCrossRef Inagaki A, Iida A, Matsubara M, Inagaki H. Positron emission tomography and magnetic resonance imaging in spinocerebellar ataxia type 2: a study of symptomatic and asymptomatic individuals. Eur J Neurol. 2005;12(9):725–8.PubMedCrossRef
32.
Zurück zum Zitat Pradhan C, Yashavantha BS, Pal PK, et al. Spinocerebellar ataxias type 1, 2 and 3: a study of heart rate variability. Acta Neurol Scand. 2008;117:337–42.PubMedCrossRef Pradhan C, Yashavantha BS, Pal PK, et al. Spinocerebellar ataxias type 1, 2 and 3: a study of heart rate variability. Acta Neurol Scand. 2008;117:337–42.PubMedCrossRef
33.
Zurück zum Zitat Sánchez-Cruz G, Velázquez-Pérez L, Gómez-Peña L, et al. Manifestaciones disautonómicas en pacientes con ataxia espinocerebelosa tipo 2 cubana. Rev Neurol. 2001;33:428–33.PubMed Sánchez-Cruz G, Velázquez-Pérez L, Gómez-Peña L, et al. Manifestaciones disautonómicas en pacientes con ataxia espinocerebelosa tipo 2 cubana. Rev Neurol. 2001;33:428–33.PubMed
34.
Zurück zum Zitat Montes-Brown J, Sánchez-Cruz G, García AM, et al. Heart rate variability in type 2 spinocerebellar ataxia. Acta Neurol Scand. 2010;122(5):329–35.PubMed Montes-Brown J, Sánchez-Cruz G, García AM, et al. Heart rate variability in type 2 spinocerebellar ataxia. Acta Neurol Scand. 2010;122(5):329–35.PubMed
35.
Zurück zum Zitat Montes-Brown J, Machado A, Estevez M, et al. Autonomic dysfunction in presymptomatic spinocerebellar ataxia type-2. Acta Neurol Scand. 2012;125(1):24–9.PubMedCrossRef Montes-Brown J, Machado A, Estevez M, et al. Autonomic dysfunction in presymptomatic spinocerebellar ataxia type-2. Acta Neurol Scand. 2012;125(1):24–9.PubMedCrossRef
36.
Zurück zum Zitat Steers WD. Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol. 2002;4 suppl 4:S7–18.PubMedCentralPubMed Steers WD. Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol. 2002;4 suppl 4:S7–18.PubMedCentralPubMed
37.
Zurück zum Zitat de Groat WC, Kawatani M. Reorganization of sympathetic preganglionic connections in cat bladder ganglia following parasympathetic denervation. J Physiol. 1989;409:431–49.PubMedCentralPubMed de Groat WC, Kawatani M. Reorganization of sympathetic preganglionic connections in cat bladder ganglia following parasympathetic denervation. J Physiol. 1989;409:431–49.PubMedCentralPubMed
38.
Zurück zum Zitat Sundin J, Dahlstrom A, Norlen L, et al. The sympathetic innervation and adrenoreceptor function on the human lower urinary tract in the normal state and after parasympathetic denervation. Investig Urol. 1977;14:322–8. Sundin J, Dahlstrom A, Norlen L, et al. The sympathetic innervation and adrenoreceptor function on the human lower urinary tract in the normal state and after parasympathetic denervation. Investig Urol. 1977;14:322–8.
40.
Zurück zum Zitat Drake MJ, Fowler CJ, Griffiths D, et al. Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms. Neurourol Urodyn. 2010;29(1):119–27.PubMedCrossRef Drake MJ, Fowler CJ, Griffiths D, et al. Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms. Neurourol Urodyn. 2010;29(1):119–27.PubMedCrossRef
42.
Zurück zum Zitat Gierga K, Bürk K, Bauer M, et al. Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2). Acta Neuropathol. 2005;109(6):617–31.PubMedCrossRef Gierga K, Bürk K, Bauer M, et al. Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2). Acta Neuropathol. 2005;109(6):617–31.PubMedCrossRef
43.
Zurück zum Zitat Rüb U, Brunt ER, Petrasch-Parwez E, et al. Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7. Neuropathol Appl Neurobiol. 2006;32(6):635–49.PubMedCrossRef Rüb U, Brunt ER, Petrasch-Parwez E, et al. Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7. Neuropathol Appl Neurobiol. 2006;32(6):635–49.PubMedCrossRef
44.
Zurück zum Zitat Medrano-Montero J, Velázquez-Pérez L, Canales-Ochoa N, et al. Electroneurography of the cranial nerves in spinocerebellar ataxia type 2. Rev Neurol. 2009;49(5):278–9.PubMed Medrano-Montero J, Velázquez-Pérez L, Canales-Ochoa N, et al. Electroneurography of the cranial nerves in spinocerebellar ataxia type 2. Rev Neurol. 2009;49(5):278–9.PubMed
45.
Zurück zum Zitat Barak O, Tsodyks M. Working models of working memory. Curr Opin Neurobiol. 2014;25C:20–4.CrossRef Barak O, Tsodyks M. Working models of working memory. Curr Opin Neurobiol. 2014;25C:20–4.CrossRef
46.
Zurück zum Zitat Manto M, Lorivel T. Cognitive repercussions of hereditary cerebellar disorders. Cortex. 2011;47:81–100.PubMedCrossRef Manto M, Lorivel T. Cognitive repercussions of hereditary cerebellar disorders. Cortex. 2011;47:81–100.PubMedCrossRef
47.
Zurück zum Zitat Monk CS, Zhuang J, Curtis WJ, et al. Human hippocampal activation in the delayed matching- and nonmatching-to-sample memory tasks: an event-related functional MRI approach. Behav Neurosci. 2002;116(4):716–21.PubMedCrossRef Monk CS, Zhuang J, Curtis WJ, et al. Human hippocampal activation in the delayed matching- and nonmatching-to-sample memory tasks: an event-related functional MRI approach. Behav Neurosci. 2002;116(4):716–21.PubMedCrossRef
48.
Zurück zum Zitat Rüb U, Farrag K, Seidel K, et al. Involvement of the cholinergic basal forebrain nuclei in Spinocerebellar ataxia type 2 (SCA2). Neuropathol Appl Neurobiol. 2013;39(6):634–43.PubMedCrossRef Rüb U, Farrag K, Seidel K, et al. Involvement of the cholinergic basal forebrain nuclei in Spinocerebellar ataxia type 2 (SCA2). Neuropathol Appl Neurobiol. 2013;39(6):634–43.PubMedCrossRef
49.
Zurück zum Zitat Hutton SB, Ettinger U. The antisaccade task as a research tool in psychopathology: a critical review. Psychophysiology. 2006;43:302–13.PubMedCrossRef Hutton SB, Ettinger U. The antisaccade task as a research tool in psychopathology: a critical review. Psychophysiology. 2006;43:302–13.PubMedCrossRef
50.
Zurück zum Zitat Rodríguez-Labrada R, Velazquez-Perez L. Eye movement abnormalities in spinocerebellar ataxias. In: Gazulla J, editor. Spinocerebellar ataxias. Rijeka: Intech; 2012. p. 59–76. Rodríguez-Labrada R, Velazquez-Perez L. Eye movement abnormalities in spinocerebellar ataxias. In: Gazulla J, editor. Spinocerebellar ataxias. Rijeka: Intech; 2012. p. 59–76.
51.
Zurück zum Zitat Ford KA, Goltz HC, Brown MR, et al. Neural processes associated with antisaccade task performance investigated with event-related FMRI. J Neurophysiol. 2005;94(1):429–40.PubMedCrossRef Ford KA, Goltz HC, Brown MR, et al. Neural processes associated with antisaccade task performance investigated with event-related FMRI. J Neurophysiol. 2005;94(1):429–40.PubMedCrossRef
52.
Zurück zum Zitat Lerche S, Berg D. The significance of identifying prodromal Parkinson’s disease. Focus Park Dis. 2014;24(1):33–7. Lerche S, Berg D. The significance of identifying prodromal Parkinson’s disease. Focus Park Dis. 2014;24(1):33–7.
53.
Zurück zum Zitat Postuma RB, Lang AE, Gagnon JF, et al. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behavior disorder. Brain. 2012;135:1860–70.PubMedCrossRef Postuma RB, Lang AE, Gagnon JF, et al. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behavior disorder. Brain. 2012;135:1860–70.PubMedCrossRef
Metadaten
Titel
Comprehensive Study of Early Features in Spinocerebellar Ataxia 2: Delineating the Prodromal Stage of the Disease
verfasst von
Luis Velázquez-Pérez
Roberto Rodríguez-Labrada
Edilia M. Cruz-Rivas
Juan Fernández-Ruiz
Israel Vaca-Palomares
Jandy Lilia-Campins
Bulmaro Cisneros
Arnoy Peña-Acosta
Yaimeé Vázquez-Mojena
Rosalinda Diaz
Jonathan J. Magaña-Aguirre
Tania Cruz-Mariño
Annelié Estupiñán-Rodríguez
José M. Laffita-Mesa
Rigoberto González-Piña
Nalia Canales-Ochoa
Yanetza González-Zaldivar
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
The Cerebellum / Ausgabe 5/2014
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-014-0574-3

Weitere Artikel der Ausgabe 5/2014

The Cerebellum 5/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.